We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
68 hedge funds and large institutions have $167M invested in State Street SPDR S&P Pharmaceuticals ETF in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
237% more call options, than puts
Call options by funds: $1.13M | Put options by funds: $334K
225% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 4
13% more funds holding
Funds holding: 60 → 68 (+8)
8% more capital invested
Capital invested by funds: $156M → $167M (+$11.7M)
0.97% more ownership
Funds ownership: 32.08% → 33.05% (+0.97%)
26% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 23
Holders
68
Holders Change
+8
Holders Change %
+13.33%
% of All Funds
1.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
17
Reduced
23
Closed
4
Calls
$1.13M
Puts
$334K
Net Calls
+$792K
Net Calls Change
+$788K
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$4.99M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.92M |
| 3 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$1.86M |
| 4 |
SI
Stephens Inc
Little Rock,
Arkansas
|
+$1.67M |
| 5 |
Jane Street
New York
|
+$1.62M |
